Shanghai, China

Jiaqiang Dong

This inventor holds 7 USPTO granted patents and 9 published patent applications and 4 EPO patents. Top assignees: Luoxin Pharmaceutical (Shanghai) Co., Ltd., Shandong Luoxin Pharmaceutical Group Stock Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Co., Ltd.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiaqiang Dong. Retrieved from https://idiyas.com/inventor/jiaqiang-dong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 71.4

 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Jiaqiang Dong: A Journey Through Patents and Collaborations

Introduction: Jiaqiang Dong, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of five patents, his work focuses on innovative solutions for medical applications, particularly in the realm of cancer treatment.

Latest Patents: Jiaqiang Dong's recent patents reflect his dedication to advancing medical science. His first notable invention is a “Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor.” This patent provides a salt form of an estrogen receptor down-regulator along with a crystalline form and its preparation method, which could potentially enhance therapeutic strategies in hormone-related diseases. The second patent he has developed is entitled “Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors.” This disclosure introduces a new class of MDM2-p53 inhibitor compounds featuring an imidaxopyrolone structure, thus representing a promising avenue for cancer treatment by manipulating critical cellular pathways.

Career Highlights: Throughout his career, Jiaqiang Dong has worked with notable companies in the pharmaceutical sector, including Luoxin Pharmaceutical (Shanghai) Co., Ltd. and Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. His experiences at these organizations have equipped him with a unique perspective on drug development and patenting processes.

Collaborations: In his pursuit of innovation, Jiaqiang has collaborated with esteemed colleagues in the field, including Tie-Lin Wang and Jianyu Lu. These partnerships have bolstered his research efforts and facilitated advancements in the development of new pharmaceutical compounds.

Conclusion: Jiaqiang Dong's contributions as an inventor are pivotal in shaping the future of pharmaceutical research. With his innovative patents and collaborative spirit, he continues to pave the way for advancements that may significantly impact cancer therapies and patient outcomes. His work exemplifies the vital role that inventors play in the improvement of healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…